BRILINTA 90 MG AstraZeneca

270.00

SKU: EU21361 Categories: ,

Description

Composition and action of BRILINTA 90 MG AstraZeneca, profile of the main ingredient

BRILINTA 90 MG, produced by AstraZeneca, is primarily composed of Ticagrelor, an antiplatelet medication that functions by inhibiting platelet aggregation. It is designed to reduce the risk of cardiovascular events in patients with acute coronary syndrome or those who have experienced a heart attack. The mechanism of action relies on Ticagrelor’s ability to block the P2Y12 receptor on platelets, leading to a reduced formation of blood clots.

In addition to its primary component, BRILINTA contains several inactive ingredients that aid in the absorption and effectiveness of the medication. These help in delivering Ticagrelor efficiently in the body, ensuring optimal performance. This attribute makes BRILINTA particularly vital for athletes and fitness enthusiasts who require enhanced recovery and decreased risks of vascular events during rigorous training sessions.

  • Active Ingredient: Ticagrelor
  • Form: Oral tablet
  • Dosing: 90 MG per tablet
  • Indication: Acute coronary syndrome prevention
  • Manufacturer: AstraZeneca

Effectiveness in training, muscle adaptation and energy

Although BRILINTA is not traditionally categorized as a performance-enhancing drug, its role in promoting better blood circulation can potentially assist athletes during intense training. Efficient blood flow is crucial in delivering oxygen and nutrients to muscle tissues. This improvement in circulation can assist in muscle adaptation, enabling athletes to experience better endurance and quicker recovery.

Moreover, the reduction of blood clot formation might lead to less fatigue during prolonged exercise. As the body adapts to training, athletes may find themselves able to push harder without the increased risk of overexertion that could result in serious cardiovascular issues. This alignment with rigorous physical demands makes BRILINTA a focus point for discussions related to sports pharmacology, especially in terms of cardiovascular health during intense training.

How to get BRILINTA 90 MG AstraZeneca online, advantages of our store

Acquiring BRILINTA 90 MG online is increasingly convenient, especially through reputable pharmacies. Before ordering, it is essential to consult with a healthcare professional to ensure that the medication aligns with your health needs, particularly if you are an athlete. Many online stores provide easy access to BRILINTA with discreet shipping options.

Our store stands out for several reasons:

  • Competitive pricing and discounts available
  • Fast and reliable shipping services
  • Accessibility for international orders
  • Customer support for queries regarding your order
  • Secure payment options ensuring privacy and safety

We prioritize customer satisfaction and health compliance, making your online shopping experience seamless.

Optimal cycle duration, when to start and stop

The optimal cycle duration for taking BRILINTA can vary depending on individual health conditions and athletic goals. Generally, it is advisable to consult with a healthcare provider to determine the precise timeline. Starting with an introductory period might help determine how your body reacts to the medication.

Typically, athletes might consider a cycle ranging from 3 to 6 months, depending on training intensity and overall cardiovascular health. It is important to monitor your body’s response closely. Stopping the medication should also be done under a healthcare provider’s guidance to prevent any adverse effects.

Possible adverse effects, important precautions

As with any medication, BRILINTA may present some adverse effects. While not every user will experience these, understanding potential risks is crucial for safety. Common adverse effects can include:

  • Bleeding or bruising more easily
  • Shortness of breath
  • Dizziness or lightheadedness
  • Nausea or vomiting

Utilizing BRILINTA requires important precautions. Individuals with a history of bleeding disorders, active bleeding, or severe liver issues should approach this medication with caution and under strict medical supervision. These factors underline the importance of comprehensive health evaluations before beginning a BRILINTA regimen, especially in a sports environment.

Additional information

Active substance

Ticagrelor

Water Retention

None

Hepatotoxicity

Low risk

Lab Test

Not specific, may monitor platelet function tests

Also known as

AZD6140

Blood pressure

Can cause transient increase

Trade name

Brilinta, Brilique, Possia

FORM

56 pills x 90 mg

Storage conditions

Store at room temperature away from moisture and heat

Chemical name

(1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Formula

C23H28F2N6O4S

Substance class

Antiplatelet agent

Main action

Platelet aggregation inhibitor

Half-life

Approximately 7 to 8.5 hours

Dosage (medical)

Typically 90 mg twice daily

Dosage (sports)

Not applicable

Effects

Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction

Side effects

Bleeding, dyspnea, headache, cough, hypertension, nausea

Use in sports

Not typically used in sports

Manufacturer

AstraZeneca

Reviews

There are no reviews yet.

Be the first to review “BRILINTA 90 MG AstraZeneca”

BRILINTA 90 MG AstraZeneca
270.00